A mind-body therapy, Mindfulness-Oriented Recovery Enhancement (MORE), increases the brain’s response to natural, healthy rewards while also decreasing the brain’s response to opioid related cues, a paper from the University of Utah reports.
“Previous research shows that prolonged use of opioids makes our brains more sensitive to pain and less receptive to the joy one might normally experience from natural rewards, like spending time with loved ones or appreciating a beautiful sunset. This blunted ability to experience natural positive feelings leads people to take higher and higher doses of opioids just to feel okay, and ultimately propels a downward spiral of opioid dependence and misuse. Because of this downward spiral, scholars are increasingly referring to chronic pain and opioid misuse as ‘diseases of despair,'”
explained Eric Garland, associate dean for research at the University of Utah College of Social Work and lead author of the study.
The research looked at data from four experiments involving 135 adults who took opioids daily for chronic pain. The study participants were randomly assigned to two groups where they participated in eight weeks of MORE or eight weeks of a therapist-led support group.
At the beginning and end of the study period, researchers collected electroencephalogram (EEG) data, which measures brain function through electrical activity at the scalp.
The results showed that over the course of the study, the brains of the study participants in the MORE group became significantly less reactive to cues related to their opioid medications, while also becoming significantly more responsive when participants used mindfulness to savor natural pleasure.
In addition to these objective EEG findings, participants in MORE also reported feeling enhanced joy and more meaning in life, results which Garland detailed in a paper published earlier this month in the Journal of Consulting and Clinical Psychology. They also reported experiencing significantly less pain and greater positive psychological health (positive emotions, the ability to savor natural pleasure and self-transcendence) than those in the support group.
The study concluded that three months after treatment, MORE reduced risk of opioid misuse by increasing positive psychological health and decreasing pain.
Garland developed MORE as an integrative mind-body therapy designed to promote positive psychological health while simultaneously addressing addiction, pain and stress. MORE teaches mental training techniques to help people to find meaning in the face of adversity while simultaneously alleviating physical and emotional pain by cultivating positive feelings and experiences.
“MORE teaches people to better notice, appreciate and amplify the good things in life, while also deriving meaning and value from difficult situations,”
Disease Of Despair
Taken together, Garland explains, these studies indicate that by changing brain function and promoting positive psychological health, MORE may increase happiness and an enhanced sense of meaningfulness in the face of adversity. These positive psychological effects, in turn, appear to reduce pain and prevent the misuse of opioids.
Thus, enhancing joy and meaning in life through mindfulness may be an antidote to diseases of despair, Garland explains.
It is estimated that approximately 20-30 percent of U.S. adults experience chronic pain. Opioid painkillers are often prescribed to these patients, but a quarter of those who take these powerful drugs long-term end up misusing them.
With opioids accounting for 63 percent of all drug overdose deaths in 2015, the widespread misuse of this class of drugs has been deemed a public health crisis.
“Our nation’s opioid crisis kills more than 100 people a day. So it is critical that we help develop new and effective ways to prevent opioid misuse. The data shows that MORE can play that key role,”
said Garland. Eric L. Garland Rachel M. Atchley, Adam W. Hanley, Jon-Kar Zubieta and Brett Froeliger. Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement. Science Advances 16 Oct 2019: Vol. 5, no. 10, eaax1569 DOI: 10.1126/sciadv.aax1569  Eric L Garland, Adam W Hanley, Michael R Riquino, Sarah E Reese, Anne K Baker, Karen Salas, Brooke P Yack, Carter E Bedford, Myranda A Bryan, Rachel Atchley, Yoshio Nakamura, Brett Froeliger, Matthew O Howard. Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial. 87(10), 927-940.
http://dx.doi.org/10.1037/ccp0000390  B. Han, W. M. Compton, C. Blanco, E. Crane, J. Lee, C. M. Jones, Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Ann. Intern. Med. 167, 293–301